MDS reports increased mass spec sales, Decreased Revenues for MDSP in Q4 of fY 2002
Earlier this month, MDS of Toronto, Canada, announced its results for the fourth quarter of its fiscal year 2002, which ended October 31.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.